An update on the clinical and molecular characteristics of pseudohypoparathyroidism

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 19, Issue 6, 2012, Pages 443-451

  Levine, Michael A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

GNAS; hormone resistance; imprinting

Indexed keywords

ALFACALCIDOL; CALCIFEDIOL; CALCITRIOL; CALCIUM; COLECALCIFEROL; ERGOCALCIFEROL; GROWTH HORMONE; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; PARATHYROID HORMONE; PARATHYROID HORMONE[1-34]; THYROTROPIN; VITAMIN D;

CALCIUM BLOOD LEVEL; CLINICAL FEATURE; DISEASE CLASSIFICATION; DISEASE SEVERITY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE; GENE LOCUS; GENE MUTATION; GENETIC TRANSCRIPTION; GENOME IMPRINTING; GNAS GENE; GROWTH HORMONE DEFICIENCY; HORMONE RESISTANCE; HUMAN; MOLECULAR PATHOLOGY; NONHUMAN; OBESITY; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN METHYLATION; PSEUDOHYPOPARATHYROIDISM; PSEUDOHYPOPARATHYROIDISM TYPE 1; REVIEW; TREATMENT INDICATION; VITAMIN BLOOD LEVEL;

ANIMALS; DNA METHYLATION; EPIGENOMICS; GENOMIC IMPRINTING; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HUMANS; MICE; MICE, KNOCKOUT; MUTATION; PSEUDOHYPOPARATHYROIDISM; THYROID GLAND;

EID: 84869878978     PISSN: 1752296X     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/MED.0b013e32835a255c     Document Type: Review

References (47)

1. Akin L, Kurtoglu S, Yildiz A, et al. Vitamin D deficiency rickets mimicking pseudohypoparathyroidism. J Clin Res Pediatr Endocrinol 2010; 2: 173-175.
2. Thiele S, de Sanctis L, Werner R, et al. Functional characterization of GNAS mutations found in patients with pseudohypoparathyroidism type Ic defines a new subgroup of pseudohypoparathyroidism affecting selectively Gsalphareceptor interaction. Hum Mutat 2011; 32:653-660.
3. Liu Z, Segawa H, Aydin C, et al. Transgenic overexpression of the extra-large Gsalpha variant XLalphas enhances Gsalpha-mediated responses in the mouse renal proximal tubule in vivo. Endocrinology 2011; 152:1222-1233.
4. Klenke S, Siffert W, Frey UH. A novel aspect of GNAS imprinting: higher maternal expression of Galphas in human lymphoblasts, peripheral blood mononuclear cells, mammary adipose tissue, and heart. Mol Cell Endocrinol 2011; 341:63-70.
5. Mouallem M, Shaharabany M, Weintrob N, et al. Cognitive impairment is prevalent in pseudohypoparathyroidism type Ia, but not in pseudopseudohypoparathyroidism: possible cerebral imprinting of Gsalpha. Clin Endocrinol (Oxf) 2008; 68:233-239.
6. Al Salameh A, Despert F, Kottler ML, et al. Resistance to epinephrine and hypersensitivity (hyperresponsiveness) to CB1 antagonists in a patient with pseudohypoparathyroidism type Ic. Eur J Endocrinol 2010; 162:819-824
7. Dekelbab BH, Aughton DJ, Levine MA. Pseudohypoparathyroidism type 1A and morbid obesity in infancy. Endocr Pract 2009; 15:249-253.
8. Mantovani G, Ferrante E, Giavoli C, et al. Recombinant human GH replacement therapy in children with pseudohypoparathyroidism type Ia: first study on the effect on growth. J Clin Endocrinol Metab 2010; 95:5011-5017.
9. Joseph AW, Shoemaker AH, Germain-Lee EL. Increased prevalence of carpal tunnel syndrome in albright hereditary osteodystrophy. J Clin Endocrinol Metab 2011; 96:2065-2073.
10. Lebrun M, Richard N, Abeguile G, et al. Progressive osseous heteroplasia: a model for the imprinting effects of GNAS inactivating mutations in humans. J Clin Endocrinol Metab 2010; 95:3028-3038.
11. Lau K, Willig RP, Hiort O, Hoeger PH. Linear skin atrophy preceding calcinosis cutis in pseudo-pseudohypoparathyroidism. Clin Exp Dermatol 2012; 37:646-648.
12. Martin J, Tucker M, Browning JC. Infantile osteoma cutis as a presentation of a GNAS mutation. Pediatr Dermatol 2012; 29:483-484.
13. Ward S, Sugo E, Verge CF, Wargon O. Three cases of osteoma cutis occurring in infancy. A brief overview of osteoma cutis and its association with pseudo-pseudohypoparathyroidism. Australas J Dermatol 2011; 52: 127-131.
14. Izzi B, Van Geet C, Freson K. Recent advances in GNAS epigenetic research of pseudohypoparathyroidism. Curr Mol Med 2012; 12:566-573.
15. Mantovani G. Clinical review: pseudohypoparathyroidism-diagnosis and treatment. J Clin Endocrinol Metab 2011; 96:3020-3030.
16. Mantovani G, Elli FM, Spada A. GNAS epigenetic defects and pseudohypoparathyroidism: time for a new classification? Horm Metab Res 2012; 44:716-723.
17. Chillambhi S, Turan S, Hwang DY, et al. Deletion of the noncoding GNAS antisense transcript causes pseudohypoparathyroidism type Ib and biparental defects of GNAS methylation in cis. J Clin Endocrinol Metab 2010; 95:3993-4002.
18. Richard N, Abeguile G, Coudray N, et al. A new deletion ablating NESP55 causes loss of maternal imprint of A/B GNAS and autosomal dominant pseudohypoparathyroidism type Ib. J Clin Endocrinol Metab 2012; 97: E863-E867.
19. Chotalia M, Smallwood SA, Ruf N, et al. Transcription is required for establishment of germline methylation marks at imprinted genes. Genes Dev 2009; 23:105-117.
20. Frohlich LF, Mrakovcic M, Steinborn R, et al. Targeted deletion of the Nesp55 DMR defines another Gnas imprinting control region and provides a mouse model of autosomal dominant PHP-Ib. Proc Natl Acad Sci USA 2010; 107:9275-9280.
21. Fernandez-Rebollo E, Perez dN, Lecumberri B, et al. Exclusion of the GNAS locus in PHP-Ib patients with broad GNAS methylation changes: evidence for an autosomal recessive form of PHP-Ib? J Bone Miner Res 2011; 26:1854-1863.
22. Fernandez-Rebollo E, Lecumberri B, Garin I, et al. New mechanisms involved in paternal 20q disomy associated with pseudohypoparathyroidism. Eur J Endocrinol 2010; 163:953-962.
23. Bastepe M, Altug-TeberO, Agarwal C, et al. Paternal uniparental isodisomy of the entire chromosome 20 as a molecular cause of pseudohypoparathyroidism type Ib (PHP-Ib). Bone 2011; 48:659-662.
24. Lietman SA, Ding C, Cooke DW, Levine MA. Reduction in Gsalpha induces osteogenic differentiation in human mesenchymal stem cells. Clin Orthop Relat Res 2005; 434:231-238.
25. Pignolo RJ, Xu M, Russell E, et al. Heterozygous inactivation ofGnas in adiposederived mesenchymal progenitor cells enhances osteoblast differentiation and promotes heterotopic ossification. J Bone Miner Res 2011; 26:2647-2655.
26. Huso DL, Edie S, Levine MA, et al. Heterotopic ossifications in a mouse model of albright hereditary osteodystrophy. PLoS One 2011; 6:e21755.
27. Linglart A, Menguy C, Couvineau A, et al. Recurrent PRKAR1A mutation in acrodysostosis with hormone resistance. N Engl J Med 2011; 364:2218-2226.
28. Michot C, Le Goff C, Goldenberg A, et al. Exome sequencing identifies PDE4D mutations as another cause of acrodysostosis. Am J Hum Genet 2012; 90:740-745.
29. Wu JY, Aarnisalo P, Bastepe M, et al. Gsalpha enhances commitment of mesenchymal progenitors to the osteoblast lineage but restrains osteoblast differentiation in mice. J Clin Invest 2011; 121:3492-3504.
30. Neary NM, El Maouche D, Hopkins R, et al. Development and treatment of tertiary hyperparathyroidism in patients with pseudohypoparathyroidism type 1b. J Clin Endocrinol Metab 2012; 97:3025-3030.
31. Long DN, Levine MA, Germain-Lee EL. Bone mineral density in pseudohypoparathyroidism type 1a. J Clin Endocrinol Metab 2010; 95:4465-4475.
32. Sbrocchi AM, Rauch F, Lawson ML, et al. Osteosclerosis in two brothers with autosomal dominant pseudohypoparathyroidism type 1b: bone histomorphometric analysis. Eur J Endocrinol 2011; 164:295-301.
33. Todorova-Koteva K, Wood K, Imam S, Jaume JC. Screening for parathyroid hormone resistance in patients with nonphenotypically evident pseudohypoparathyroidism. Endocr Pract 2012; pp. 1-21.
34. Lindsay R, Nieves J, Henneman E, et al. Subcutaneous administration of the amino-terminal fragment of human parathyroid hormone-(1-34): kinetics and biochemical response in estrogenized osteoporotic patients. J Clin Endocrinol Metab 1993; 77:1535-1539.
35. de Nanclares GP, Fernandez-Rebollo E, Santin I, et al. Epigenetic defects of GNAS in patients with pseudohypoparathyroidism and mild features of Albright's hereditary osteodystrophy. J Clin Endocrinol Metab 2007; 92:2370-2373.
36. Sanchez J, Perera E, Jan dB, et al. Madelung-like deformity in pseudohypoparathyroidism type 1b. J Clin Endocrinol Metab 2011; 96:E1507-E1511.
37. Zazo C, Thiele S, Martin C, et al. Gsalpha activity is reduced in erythrocyte membranes of patients with psedohypoparathyroidism due to epigenetic alterations at the GNAS locus. J Bone Miner Res 2011; 26:1864-1870.
38. Freson K, Thys C, Wittevrongel C, et al. Pseudohypoparathyroidism type Ib with disturbed imprinting in the GNAS1 cluster and Gsalpha deficiency in platelets. Hum Mol Genet 2002; 11:2741-2750.
39. Freson K, Izzi B, Labarque V, et al. GNAS defects identified by stimulatory G protein alpha-subunit signalling studies in platelets. J Clin Endocrinol Metab 2008; 93:4851-4859.
40. Izzi B, Francois I, Labarque V, et al. Methylation defect in imprinted genes detected in patients with an Albright's hereditary osteodystrophy like phenotype and platelet Gs hypofunction. PLoS One 2012; 7:e38579.
41. Singh GK, Verma V. Progressive osseous heteroplasia in a 10-year-old male child. Indian J Orthop 2011; 45:280-282.
42. Adegbite NS, Xu M, Kaplan FS, et al. Diagnostic and mutational spectrum of progressive osseous heteroplasia (POH) and other forms of GNASbased heterotopic ossification. Am J Med Genet A 2008; 146A:1788-1796.
43. Maupetit-Mehouas S, Mariot V, Reynes C, et al. Quantification of the methylation at the GNAS locus identifies subtypes of sporadic pseudohypoparathyroidism type Ib. J Med Genet 2011; 48:55-63.
44. Mantovani G, de Sanctis L, Barbieri AM, et al. Pseudohypoparathyroidism and GNAS epigenetic defects: clinical evaluation of albright hereditary osteodystrophy and molecular analysis in 40 patients. J Clin Endocrinol Metab 2010; 95:651-658.
45. Izzi B, Decallonne B, Devriendt K, et al. A new approach to imprinting mutation detection in GNAS by Sequenom EpiTYPER system. Clin Chim Acta 2010; 411:2033-2039.
46. Mitsui T, Nagasaki K, Takagi M, et al. A family of pseudohypoparathyroidism type Ia with an 850-kb submicroscopic deletion encompassing the whole GNAS locus. Am J Med Genet A 2011. doi: 10.1002/ajmg.a.34393.
47. Fernandez-Rebollo E, Garcia-Cuartero B, Garin I, et al. Intragenic GNAS deletion involving exon A/B in pseudohypoparathyroidism type 1A resulting in an apparent loss of exon A/B methylation: potential for misdiagnosis of pseudohypoparathyroidism type 1B. J Clin Endocrinol Metab 2010; 95: 765-771.